Ideaya is a California-based biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of cancer.Read more
IDEAYA's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 216.3M. Over the last four quarters, IDEAYA's revenue has decreased by 2.4%. Specifically, in Q2 2021's revenue was $8.8M; in Q1 2021, it was $7.2M; in Q4 2020, it was $10.6M; in Q3 2020, IDEAYA's revenue was $9M.